{"id":"clinoleic-omegaven","safety":{"commonSideEffects":[{"rate":null,"effect":"Hypertriglyceridemia"},{"rate":null,"effect":"Infusion site reactions"},{"rate":null,"effect":"Hepatic dysfunction"},{"rate":null,"effect":"Thrombocytopenia"}]},"_chembl":{"chemblId":"CHEMBL4297535","moleculeType":"Unknown"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"ClinOleic is a mixed lipid emulsion containing soybean oil, medium-chain triglycerides, olive oil, and fish oil that provides balanced essential fatty acids and energy. Omegaven is a fish oil-based lipid emulsion rich in omega-3 polyunsaturated fatty acids (EPA and DHA). Together, they support nutritional requirements in patients unable to receive adequate oral or enteral nutrition, while the omega-3 component may help reduce inflammatory responses and support immune function.","oneSentence":"ClinOleic + Omegaven is a combination intravenous lipid emulsion that provides essential fatty acids and omega-3 fatty acids for parenteral nutrition support.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:30:13.826Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Parenteral nutrition in patients unable to receive adequate oral or enteral nutrition"},{"name":"Nutritional support in critically ill patients, particularly those at risk of lipid-related complications"}]},"trialDetails":[{"nctId":"NCT03869957","phase":"NA","title":"Effect of Parenteral Nutrition With n-3 PUFAs on Patients With Intestinal Failure","status":"COMPLETED","sponsor":"Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran","startDate":"2019-12-01","conditions":"Intestinal Failure","enrollment":20},{"nctId":"NCT03149653","phase":"PHASE4","title":"Crossover Study on the Effect of Omegaven in Combination With Different Lipid Emulsions in Home Parenteral Nutrition","status":"COMPLETED","sponsor":"General University Hospital, Prague","startDate":"2012-01-15","conditions":"Parenteral Nutrition","enrollment":24}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["ClinOleic 20% Baxter + Omegaven 10% Fresenius Kabi"],"phase":"marketed","status":"active","brandName":"ClinOleic + Omegaven","genericName":"ClinOleic + Omegaven","companyName":"General University Hospital, Prague","companyId":"general-university-hospital-prague","modality":"Small molecule","firstApprovalDate":"","aiSummary":"ClinOleic + Omegaven is a combination intravenous lipid emulsion that provides essential fatty acids and omega-3 fatty acids for parenteral nutrition support. Used for Parenteral nutrition in patients unable to receive adequate oral or enteral nutrition, Nutritional support in critically ill patients, particularly those at risk of lipid-related complications.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}